Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks.

Feld JJ, Moreno C, Trinh R. Sustained virologic response of 100% in HCV genotype 1b patients with cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12 weeks. J Hepatol . 2016;64(2):301-307.

Publication Type:

Journal Article

Authors:

J J Feld; Moreno, C.; Trinh, R.

Source:

J Hepatol , Volume 64, Issue 2, p.301-307 (2016)

Cited On:

Export Citation:
RIS Format
Top